PYC Therapeutics | PYC - Stammkapital

Aktienkurs
1.18
Täglich Wechseln
0.06 5.38%
Monatlich
-21.40%
Jährlich
19.90%
Q2 Prognose
1.15




Stammkapital Veränderung Datum
Medical Developments International AUD 112.66M 2.35M 2025-12
Neuren Pharmaceuticals AUD 126.64M 38.63M 2025-12
Pacific Edge NZD 1.02B 210.22M 2025-12
Paradigm Biopharmaceuticals AUD 428.52M 39.09M 2025-12
Telix Pharmaceuticals AUD 338.78M 379K 2025-12